Announcements Trials

Browse Landscape

Status

Completed 7 Unknown 2 Terminated 2 Recruiting 2 Active not recruiting 2 Not yet recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Leukemia, Myeloid, Acute 1 Leukemia 1 Breast Neoplasms 1 Breast Cancer Early Stage Breast Cancer (Stage 1-3) 1

Interventions

Trastuzumab 16 pertuzumab 14 Capecitabine 14 Docetaxel 12 pyrotinib 11 Cyclophosphamide 11 Standard of Care 10 Paclitaxel 10 Letrozole 10 trastuzumab deruxtecan 9 Radiotherapy 9 Carboplatin 9 Fulvestrant 8 Drug Therapy 8 sacituzumab govitecan 7 dalpiciclib 7 exemestane 6 eribulin 6 Tamoxifen 6 Epirubicin 6 Anastrozole 6 pembrolizumab 5 palbociclib 5 abemaciclib 5 Surveys and Questionnaires 5 Neoadjuvant Therapy 5 Aromatase Inhibitors 5 camrelizumab 4 Sentinel Lymph Node Biopsy 4 Doxorubicin 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Breast Neoplasms × Anthracyclines × Clear all

NCT06684054 2024-11-12

STFREiYTNBC

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

Not yet recruiting

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡